Company news

Share this article:
Valeant Pharmaceuticals has announced a definitive agreement to acquire Dow Pharmaceutical Sciences, a privately held dermatology company, for $285 million. Dow Pharmaceutical Sciences' current annualized revenues are approximately $45 million, of which roughly $20 million represents royalty payments from licensed products.
 
Wyeth will cut 276 workers in Puerto Rico as a result of decreasing demand for locally manufactured products. The layoffs will be completed by February 2009, with 2,700 workers remaining across three plants in the US Caribbean territory, the AP reported.
 
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Apple selfies spur diabetes donations

Jazz apples has launched a Crunch to Contribute campaign to raise money for one of two diabetes associations.

Baxter seeks Cambridge, Mass. HQ

Illinois may be tempted to offer tax incentives for the firm to stay put.

FDA wants Alexion to clean up

FDA inspectors have cited the manufacturer of the rare-disease drug Soliris (eculizumab) for poor manufacturing practices.